Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07733908) titled 'Effectiveness of Posluma PET Scan for Post-Treatment Monitoring of Prostate Cancer' on July 25.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).

Primary Sponsor: Aditya Bagrodia

Condition: Prostate Cancer

Intervention: Diagnostic Test: Posluma PET

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: August 2026

Target Sample Size: 22

To know more, visit https://clinicaltrials.gov/study/NCT07733908

Disclaimer: Curated by HT Syndication....